[1]查鹏 综述 梁正**审校.胸腔镜肺段切除术治疗磨玻璃结节的研究进展[J].中国微创外科杂志,2020,01(9):843-847.
点击复制

胸腔镜肺段切除术治疗磨玻璃结节的研究进展()
分享到：

《中国微创外科杂志》[ISSN:1009-6604/CN:11-4526/R]

卷:
01
期数:
2020年9期
页码:
843-847
栏目:
文献综述
出版日期:
2020-09-25

文章信息/Info

作者:
查鹏 综述 梁正**审校
（北京大学国际医院胸外科，北京102206）
文献标志码:
A

参考文献/References:

[1]Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2018, 68(6): 394-424.
[2]Chen W, Zheng R, Baade PD,et al.Cancer statistics in China,2015.CA Cancer J Clin,2016,66(2): 115-132.
[3]Hirsch FR, Scagliotti GV, Mulshine JL, et al. Lung cancer: current therapies and new targeted treatments. Lancet,2017,389(10066):299-311.
[4]National Lung Screening Trial Research Team, Aberle DR, Adams AM, et al. Reduced lungcancer mortality with lowdose computed tomographic screening. N Engl J Med, 2011, 365(5): 395-409.
[5]姜格宁, 陈昶, 朱余明, 等. 上海市肺科医院磨玻璃结节早期肺腺癌的诊疗共识（第一版）. 中国肺癌杂志, 2018, 21（3）: 147-159.
[6]朱征, 张明, 王勇, 等. 单孔全胸腔镜解剖性肺段切除术治疗早期非小细胞肺癌. 中国微创外科杂志,2019,19（10）:887-889,893.
[7]Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 nonsmall cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg,1995,60(3):615-622.
[8]Ettinger DS, Akerley W,Bepler G, et al. Nonsmall cell lung cancer.J Natl Compr Canc Netw, 2010,8(7):740-801.
[9]Postmus PE, Kerr KM, Oudkerk M, et al. Early and locally advanced nonsmallcell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and followup. Ann Oncol, 2017,28(suppl_4):iv1-iv21.
[10]中华医学会呼吸病学分会肺癌学组，中国肺癌防治联盟专家组. 肺结节诊治中国专家共识（2018年版）. 中华结核和呼吸杂志, 2018, 41(10):763-771.
[11]MacMahon H, Naidich DP, Goo JM, et al. Guidelines for management of incidental pulmonary nodules detected on CT images: from the Fleischner Society 2017. Radiology,2017, 284(1):228-243.
[12]American College of Radiology. Lung CT Screening Reporting and Data System (LungRADS) . Accessed at www.acr.org/QualitySafety/Resources/LungRADS.
[13]王群, 蒋伟, 王琳, 等. 肺部磨玻璃结节的处理原则和共识及手术技巧. 中华肿瘤杂志, 2019,41（1）:6-9.
[14]Mironova V, Blasberg JD. Evaluation of ground glass nodules. Curr Opin Pulm Med, 2018, 24 (4): 350-354.
[15]蔡雅倩, 张正华, 韩丹, 等. AI对肺磨玻璃结节筛查及定性的临床应用研究. 放射性实践, 2019,34（9）:958-962.
[16]钱鑫, 张岩, 崔有斌, 等. 3DCTBA 指导下全胸腔镜下解剖性肺段切除术治疗老年早期非小细胞肺癌的疗效. 中国老年学杂志, 2019, 39（19）: 4718-4720.
[17]Wood DE, Kazerooni EA, Baum SL, et al. Lung Cancer Screening, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw,2018,16(4):412-441.
[18]王俊峰, 付玉东, 阚强波, 等. 全胸腔镜解剖性肺段切除术30例. 中国微创外科杂志, 2016, 16（11）: 1013-1015.
[19]张瑞杰, 蔡奕欣, 张霓, 等. 3 cm 单孔胸腔镜在解剖性肺段切除术中的应用. 中国微创外科杂志, 2016, 16(1): 50-52, 56.
[20]Hou B, Deng XF, Zhou D, et al. Segmentectomy versus wedge resection for the treatment of highrisk operable patients with stage Ⅰ nonsmall cell lung cancer: a metaanalysis. Ther Adv Respir Dis, 2016, 10( 5) : 435-443.
[21]中华医学会, 中华医学会肿瘤学分会, 中华医学会杂志社. 中华医学会肺癌临床诊疗指南（2018 版）. 中华肿瘤杂志, 2018, 40（12）: 935-964.
[22]Suzuki K, Saji H, Aokage K, et al. Comparison of pulmonary segmentectomy and lobectomy:safety results of a randomized trial. J Thorac Cardiovasc Surg, 2019, 158(3): 895-907.
[23]Altorki NK, Wang X, Wigle D, et al. Perioperative mortality and morbidity after sublobar versus lobar resection for earlystage nonsmall cell lung cancer: posthoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503). Lancet Respir Med, 2018,6 (12): 915-924.
[24]刘士学, 王君, 徐美清, 等. 全胸腔镜下解剖性肺段切除41 例临床分析. 中国微创外科杂志, 2016, 16（12）: 1127-1130.
[25]钟斌, 吴奇勇, 童继春, 等. 胸腔镜肺段或肺叶切除术治疗肺磨玻璃结节的比较研究. 中国微创外科杂志,2017,17（1）：62-64,68.
[26]陈亮, 吴卫兵. 胸腔镜解剖性肺段切除术技术要点. 中国肺癌杂志,2016,19(6):377-381.
[27]陈亮, 王俊, 吴卫兵, 等. 胸腔镜精准肺段切除术技术流程和质量控制. 中国胸心血管外科临床杂志, 2019, 26（1）: 21-28.
[28]孙超, 陆世春, 王霄霖, 等. 三维重建技术在胸腔镜解剖性肺段切除术中的应用. 中国微创外科杂志,2019,19（2）：115-117.
[29]Yao F, Wang J, Yao J, et al. Threedimensional image reconstruction with free opensource OsiriX software in videoassisted thoracoscopic lobectomy and segmentectomy. Int J Surg,2017, 39: 16-22.
[30]中国医药教育协会胸外科专业委员会, 中国胸外科肺癌联盟, 浙江省医学会胸外科学分会, 等. 人工智能平台下肺结节的三维可视化定位与手术规划专家共识. 中国胸心血管外科临床杂志, 2019, 26（12）：1161-1166.
[31]Hamada A, Oizumi H, Kato H, et al. Learning curve for portaccess thoracoscopic anatomic lung segmentectomy. J Thorac Cardiovasc Surg, 2018, 156（5）:1995-2003.
[32]陈醒狮, 金润森, 李鹤成,等. 肺段切除术中段间平面处理方式的研究进展.中国微创外科杂志,2019,19（2）：190-192.
[33]郑鑫林, 夏学阳, 张金周,等. 胸腔镜下肺段切除与肺叶切除治疗临床Ⅰ期非小细胞肺癌疗效对比的Meta 分析. 中国癌症杂志, 2016, 26(10): 854-860.
[34]戚胜波, 刘永靖, 陶宇. 胸腔镜肺叶切除术与肺段切除术治疗早期肺癌的临床分析. 临床肺科杂志, 2020, 25（5）: 740-743, 744.
[35]Yao F, Wang J, Yao J, et al. Early experience with videoassisted thoracoscopic anatomic segmentectomy. J Laparoendosc Adv Surg Tech A, 2018, 28(7): 819-826.
[36]Lin Y, Zheng W, Zhu Y, et al. Comparison of treatment outcomes between singleport videoassisted thoracoscopic anatomic segmentectomy and lobectomy for nonsmall cell lung cancer of earlystage: a retrospective observational study. J Thorac Dis, 2016, 8(6): 1290-1296.
[37]Charloux A, Quoix E. Lung segmentectomy: does it offer a real functional benefit over lobectomy? Eur Respir Rev, 2017, 26(146):170079.
[38]吕宏伟, 李印, 周美宏, 等. 肺段与肺叶切除术对早期肺癌术后肺功能影响的meta分析. 中华胸心血管外科杂志, 2019, 33（9）: 534-538.
[39]Nomori H, Shiraishi A, Cong Y, et al. Differences in postoperative changes in pulmonary functions following segmentectomy compared with lobectomy. Eur J Cardiothorac Surg,2018, 53 (3): 640-647.
[40]Kent MS, Mandrekar SJ, Landreneau R, et al. Impact of sublobar resection on pulmonary function: longterm results from American College of Surgeons Oncology Group Z4032 (Alliance). Ann Thorac Surg, 2016, 102(1): 230-238.
[41]周逸鸣，宋楠，朱余明，等. 单中心连续1817 例早期肺癌诊疗经验. 中华胸心血管外科杂志, 2017,33(11):655-657.
[42]朱训夏，武韫，吕帆真，等. 亚肺叶切除术与肺叶切除术治疗老年磨玻璃结节的疗效比较. 老年医学与保健,2017,23(3):183-185.
[43]Asamura H, Hishida T, Suzuki K, et al. Radiographically determined noninvasive adenocarcinoma of the lung: survival outcomes of Japan Clinical Oncology Group 0201. J Thorac Cardiovasc Surg, 2013, 146(1):24-30.
[44]Okada M, Koike T, Higashiyama M, et al. Radical sublobar resection for smallsized nonsmall cell lung cancer: a multicenter study. J Thorac Cardiovasc Surg, 2006, 132(4): 769-775.
[45]Sagawa M, Oizumi H, Suzuki H, et al. A prospective 5year followup study after limited resection for lung cancer with groundglass opacity. Eur J Cardiothorac Surg, 2018, 53(4):849-856.
[46]Moon Y, Lee KY, Park JK. The prognosis of invasive adenocarcinoma presenting as groundglass opacity on chest computed tomography after sublobar resection. J Thorac Dis, 2017, 9(10):3782-3792.
[47]Khullar OV, Liu Y, Gillespie T, et al. Survival after sublobar resection versus lobectomy for clinical stage Ia lung cancer: an analysis from the National Cancer Data Base. J Thorac Oncol, 2015, 10(11): 1625-1633.
[48]Yano M, Yoshida J, Koike T, et al. The outcomes of a limited resection for nonsmall cell lung cancer based on differences in pathology. World J Surg, 2016, 40(11): 2688-2697.
[49]Qian F, Yang W, Wang R, et al. Prognostic significance and adjuvant chemotherapy survival benefits of a solid or micropapillary pattern in patients with resected stage Ib lung adenocarcinoma. J Thorac Cardiovasc Surg, 2018, 155(3): 1227-1235. e2.
[50]Xiao F, Yu Q, Zhang Z, et al. Novel perspective to evaluate the safety of segmentectomy: clinical significance of lobar and segmental lymph node metastasis in cT1N0M0 lung adenocarcinoma. Eur J Cardiothorac Surg,2018, 53(1): 228-234.
[51]Dembitzer FR, Flores RM, Parides MK, et al. Impact of histologic subtyping on outcome in lobar vs sublobar resections for lung cancer: a pilot study. Chest, 2014, 146(1): 175-181.
[52]Zhao ZR, Situ DR, Lau RW, et al. Comparison of segmentectomy and lobectomy in stage Ia adenocarcinomas. J Thorac Oncol, 2017, 12(5):890-896.

备注/Memo

备注/Memo:
基金项目：北京大学国际医院院内课题（YN2019QN09）**通讯作者，Email：liangzheng@pkuih.edu.cn
更新日期/Last Update: 2020-12-09